Logo image of GXAI

GAXOS.AI INC (GXAI) Stock Fundamental Analysis

NASDAQ:GXAI - Nasdaq - US62911P3001 - Common Stock - Currency: USD

1.19  +0.06 (+5.31%)

After market: 1.1898 0 (-0.02%)

Fundamental Rating

2

Overall GXAI gets a fundamental rating of 2 out of 10. We evaluated GXAI against 72 industry peers in the Entertainment industry. While GXAI has a great health rating, there are worries on its profitability. GXAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GXAI has reported negative net income.
In the past year GXAI has reported a negative cash flow from operations.
GXAI Yearly Net Income VS EBIT VS OCF VS FCFGXAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -1M -2M -3M

1.2 Ratios

GXAI has a worse Return On Assets (-55.45%) than 87.50% of its industry peers.
With a Return On Equity value of -58.80%, GXAI is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -55.45%
ROE -58.8%
ROIC N/A
ROA(3y)-86.13%
ROA(5y)N/A
ROE(3y)-107.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GXAI Yearly ROA, ROE, ROICGXAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GXAI Yearly Profit, Operating, Gross MarginsGXAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -200K -400K -600K -800K -1M

More info and screens

8

2. Health

2.1 Basic Checks

GXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GXAI has more shares outstanding
GXAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GXAI Yearly Shares OutstandingGXAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 200K 400K 600K 800K 1M
GXAI Yearly Total Debt VS Total AssetsGXAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1M 2M 3M

2.2 Solvency

GXAI has an Altman-Z score of 9.28. This indicates that GXAI is financially healthy and has little risk of bankruptcy at the moment.
GXAI's Altman-Z score of 9.28 is amongst the best of the industry. GXAI outperforms 94.44% of its industry peers.
There is no outstanding debt for GXAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.28
ROIC/WACCN/A
WACC9.01%
GXAI Yearly LT Debt VS Equity VS FCFGXAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M

2.3 Liquidity

A Current Ratio of 17.12 indicates that GXAI has no problem at all paying its short term obligations.
The Current ratio of GXAI (17.12) is better than 97.22% of its industry peers.
GXAI has a Quick Ratio of 17.12. This indicates that GXAI is financially healthy and has no problem in meeting its short term obligations.
GXAI has a Quick ratio of 17.12. This is amongst the best in the industry. GXAI outperforms 97.22% of its industry peers.
Industry RankSector Rank
Current Ratio 17.12
Quick Ratio 17.12
GXAI Yearly Current Assets VS Current LiabilitesGXAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

GXAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -143.90%.
EPS 1Y (TTM)-143.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GXAI Yearly Revenue VS EstimatesGXAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 50 100 150 200 250

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GXAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GXAI Price Earnings VS Forward Price EarningsGXAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GXAI Per share dataGXAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GAXOS.AI INC

NASDAQ:GXAI (5/9/2025, 8:00:01 PM)

After market: 1.1898 0 (-0.02%)

1.19

+0.06 (+5.31%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.63%
Inst Owner Change0%
Ins Owners3.26%
Ins Owner ChangeN/A
Market Cap8.23M
AnalystsN/A
Price TargetN/A
Short Float %1.58%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27449.33
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)-4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0
BVpS0.97
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.45%
ROE -58.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-86.13%
ROA(5y)N/A
ROE(3y)-107.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 505.41%
Cap/Sales 68566.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.12
Quick Ratio 17.12
Altman-Z 9.28
F-Score5
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-143.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-178.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-129.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.48%
OCF growth 3YN/A
OCF growth 5YN/A